Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine rectus sheath block plus PCIA for pain after single-port gynecologic laparoscopy
ChiCTR2500102369Phase 4Not yet recruiting
- Sponsor
- West China Tianfu Hospital
- Start
- May 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in acute postoperative pain (2 arms), sponsored by West China Tianfu Hospital. Primary endpoint: Area under the 72-hour pain score curve. Planned start May 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2500102369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102369.